Linezolid Teva

Linezolid, the active ingredient in Linezolid Teva, is an oxazolidinone presented as an oral tablet for systemic use. It is indicated for the treatment of serious Gram‑positive bacterial infections, including skin and soft‑tissue infections and certain types of pneumonia, in adult patients when alternative therapies are unsuitable.

GNH USA supplies Linezolid Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Linezolid is an oxazolidinone antibiotic used to treat infections caused by susceptible Gram‑positive bacteria. - Gram‑positive bacterial infections: eradicates resistant strains such as MRSA and VRE, improving clinical outcomes. - Skin and soft tissue infections: resolves cellulitis, abscesses, and wound infections caused by susceptible organisms. - Community‑acquired pneumonia: provides effective therapy against atypical and typical Gram‑positive pathogens. - Nosocomial pneumonia: treats hospital‑acquired lower respiratory infections when other agents are ineffective.

Adverse reactions may occur with linezolid therapy and are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools that may be self‑limiting. - Headache: transient cranial discomfort. - Metallic taste: altered taste perception during treatment.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count requiring monitoring. - Peripheral neuropathy: sensory changes that may be irreversible. - Serotonin syndrome: risk when combined with serotonergic agents. - Optic neuritis: visual disturbances that necessitate immediate evaluation.

Clinicians should consider several safety measures before and during linezolid therapy. - Monitor blood counts: regular CBC to detect thrombocytopenia or anemia. - Assess renal function: adjust use in patients with severe impairment. - Avoid serotonergic drugs: co‑administration can precipitate serotonin syndrome. - Use caution in hepatic disease: liver dysfunction may affect drug metabolism. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Linezolid may interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - MAO inhibitors: concurrent use can cause hypertensive crisis. - Serotonergic agents (SSRIs, SNRIs, Triptans): increase risk of serotonin syndrome.

Moderate Interactions (Monitor Closely): - Rifampin: induces metabolism, reducing linezolid plasma levels. - Warfarin: may enhance anticoagulant effect, requiring INR monitoring. - NSAIDs: combined use can raise bleeding risk, especially with thrombocytopenia.